Clinical Trials
10
Active:0
Completed:1
Trial Phases
5 Phases
Phase 1:1
Phase 2:1
Phase 3:1
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (10 trials with phase data)• Click on a phase to view related trials
Not Applicable
5 (50.0%)Phase 4
2 (20.0%)Phase 1
1 (10.0%)Phase 2
1 (10.0%)Phase 3
1 (10.0%)Effectiveness of Aurix Therapy in Venous Leg Ulcers
Phase 4
Withdrawn
- Conditions
- Venous Leg Ulcers
- First Posted Date
- 2016-10-21
- Last Posted Date
- 2016-10-21
- Lead Sponsor
- Cytomedix
- Registration Number
- NCT02940587
- Locations
- 🇺🇸
St. Luke's Intermountain Research, Boise, Idaho, United States
A Prospective, Randomized, Controlled, Multi-Center, Study Evaluating AutoloGel Therapy for Complete Closure of Wagner Grade 1-4 Diabetic Foot Ulcers, Venous Leg Ulcers and Stage II-IV Pressure Ulcers
Phase 4
Withdrawn
- Conditions
- Impaired Wound Healing
- First Posted Date
- 2014-09-25
- Last Posted Date
- 2016-10-21
- Lead Sponsor
- Cytomedix
- Registration Number
- NCT02248077
AutoloGel Therapy to Usual and Customary Care in Pressure Ulcers
Not Applicable
Terminated
- Conditions
- Pressure Ulcer
- First Posted Date
- 2013-03-27
- Last Posted Date
- 2016-10-21
- Lead Sponsor
- Cytomedix
- Target Recruit Count
- 2
- Registration Number
- NCT01819142
- Locations
- 🇺🇸
Singing River, Pascagaula, Mississippi, United States
A Cohort Trial Comparing AutoloGel Therapy to Usual and Customary Care in Venous Leg Ulcers
Not Applicable
Terminated
- Conditions
- Venous Leg Ulcer
- First Posted Date
- 2013-03-25
- Last Posted Date
- 2016-10-21
- Lead Sponsor
- Cytomedix
- Target Recruit Count
- 2
- Registration Number
- NCT01817543
- Locations
- 🇺🇸
HyperBarxs at Northside Forsyth, Cumming, Georgia, United States
Efficacy of AutoloGel Therapy to Usual and Customary Care in Wagner gd 1 and 2 Diabetic Foot Ulcers.
Not Applicable
Terminated
- Conditions
- Diabetic Foot Ulcer
- First Posted Date
- 2013-03-22
- Last Posted Date
- 2016-10-21
- Lead Sponsor
- Cytomedix
- Target Recruit Count
- 4
- Registration Number
- NCT01816672
- Locations
- 🇺🇸
Forest General Hospital, Hattiesburg, Mississippi, United States
- Prev
- 1
- 2
- Next
News
No news found